The molecular biology company will join the Tobacco Dock event to demonstrate its clinical approach to NAD+ regeneration and cellular health.
At a time when the extra aisle is becoming increasingly crowded with the latest “must-have” molecules, Nuchido comes with a refreshing commitment to the rigors of molecular biology. The British company, which has carved out a niche in the crowded NAD+ landscape, will join the Longevity Show at Tobacco Dock as a Catalyst Partner. While many in the field are content to chase longevity “trends,” Nuchido has spent the better part of a decade quietly interrogating the mechanics of cell decline; it’s an approach that prioritizes biological logic over marketing shortcuts.
Rather than treating the body as a passive vessel to be “filled” with external precursors, Nuchido’s philosophy is based on the belief that the most effective longevity interventions are those that restore the body’s innate capacity for self-repair. By moving away from the simple “replacement” model, the company’s advanced formula, Nuchido TIME+ helps to define a new era of heroism, the purpose of which is not only to complete, but also to restart the mechanism of youth unemployment.
Longevity.Technology: The NAD+ sector has matured beyond the initial excitement of simple precursors, but it remains a crowded market, often dominated by consumer confusion; Nuchido differs by abandoning the “above” model in favor of a complex systems-biological approach. By targeting NAMPT—the rate-limiting enzyme in the survival pathway—and inhibiting the inflammatory “drainage” of CD38, the company is addressing the underlying mechanics of cell decline rather than simply treating the exhaustion symptom. It’s refreshing to see a partner with randomized, double-blind, placebo-controlled human data in a category often criticized for relying on “borrowed” science. Dr. Nicola Conlon’s presence at the Longevity Show as both a keynote speaker and a keynote speaker on the discovery stage provides an important opportunity for attendees to look under the hood of cellular metabolism; his research philosophy sets a necessary benchmark for the industry – proving that restoration is far more elegant than simple replacement. Science, not trends.
Addressing the root cause of NAD+ depletion
The main problem with aging at the cellular level is not only the loss of vital molecules, but also the breakdown of the pathways that produce them. Central to Nuchido’s strategy is the regulation of NAMPT, the rate-limiting enzyme responsible for the NAD+ salvage pathway. As we age, NAMPT levels decline and cells are unable to recycle raw materials for energy production and DNA repair (1). By coupling this regulation with inhibition of CD38—an inflammatory enzyme known to “leak” cellular resources—Nuchido proposes a two-pronged intervention that is as scientifically sound as it is innovative.
Clinical transparency and the road to Tobacco Dock
This evidence-based philosophy is backed by randomized, double-blind, placebo-controlled human clinical trials that have shown significant increases in cellular NAD+ levels along with improvements in key signs of aging, including inflammation, glycation, and biological age.2). It is this level of clinical transparency that elevates Nouchido above the fray. Participants in the Longevity Show have the opportunity to interact directly with this data and move beyond the anecdotal to the analytical.
Phil Newman, CEO of Longevity.Technology, commented on the partnership: “We are delighted to welcome Nouchido as a catalyst partner for the Longevity Show as they translate cutting-edge longevity science into real-world impact. Their clinically proven work in NAD+ regeneration and cellular health research demonstrates how cellular health products can be promoted. Longevity, led by molecular biologist Dr. Nicola Conlon, Nouchido is a golden example of longevity innovation that aligns perfectly with our mission to expand health and longevity at this year’s Tobacco Dock event and beyond.
Look at the technique
The educational component of the partnership is probably its most important added value. Nuchido’s founder, Dr. Nicola Conlon, will take to the stage twice during the event – once as a keynote speaker and again during the discovery phase. On day 1, he held a session entitled NAD+: Separating the Hype from the Scienceexploring how chronic inflammation is at the root of age-related conditions. The session is designed to cut through the noise and offer key insights into how protocols such as cold exposure, hyperbaric therapy, movement and nutrition can be used to reduce inflammation and optimize individual health.
His sessions are expected to break the veil of cellular metabolism and provide a masterclass in how to translate herology into practical, everyday protocols. For Nuchido, this event is an important moment to bridge the gap between the laboratory and the hotel.
“At Nuchido, our mission has always been to bridge the gap between cutting-edge longevity science and everyday health through both our products and our commitment to education,” says Conlon. “That’s why it’s so encouraging to see the UK increasingly embracing this space, with events like the Longevity Show creating a platform to bring together innovative products and expert speakers.”
To learn more about partnership and exhibitor opportunities at The Longevity Show 2026, Contact the sponsor and exhibitor team.
The Longevity Fair opens its doors on 26-27 June 2026 at Tobacco Dock, London. Tickets for all levels are now available on the site www.longevityshow.com.
Photos by Nuchido
(1) https://www.researchgate.net/publication/306312038_It_takes_two_to_tango_NAD_and_sirtuins_in_aginglongevity_control
(2) https://www.nature.com/articles/s41514-023-00134-0
